User menu

Locomotor dysfunction and pain: the scylla and charybdis of fiber sprouting after spinal cord injury.

Bibliographic reference Deumens, Ronald ; Joosten, Elbert A J ; Waxman, Stephen G ; Hains, Bryan C. Locomotor dysfunction and pain: the scylla and charybdis of fiber sprouting after spinal cord injury.. In: Molecular Neurobiology : a review journal, Vol. 37, no.1, p. 52-63 (2008)
Permanent URL http://hdl.handle.net/2078.1/125367
  1. Sekhon LH, Fehlings MG (2001) Epidemiology, demographics, and pathophysiology of acute spinal cord injury. Spine 26:S2–S12
  2. Balazy TE (1992) Clinical management of chronic pain in spinal cord injury. Clin J Pain 8:102–110
  3. Richards JS, Meredith RL, Nepomuceno C, Fine PR, Bennett G (1980) Psycho-social aspects of chronic pain in spinal cord injury. Pain 8:355–366
  4. Christensen MD, Hulsebosch CE (1997a) Chronic central pain after spinal cord injury. J Neurotrauma 14:517–537
  5. Christensen MD, Hulsebosch CE (1997b) Spinal cord injury and anti-NGF treatment results in changes in CGRP density and distribution in the dorsal horn in the rat. Exp Neurol 147:463–475
  6. Finnerup NB, Johannesen IL, Sindrup SH, Bach FW, Jensen TS (2001) Pain and dysesthesia in patients with spinal cord injury: a postal survey. Spinal Cord 39:256–262
  7. Siddall PJ, McClelland JM, Rutkowski SB, Cousins MJ (2003) A longitudinal study of the prevalence and characteristics of pain in the first 5 years following spinal cord injury. Pain 3:249–257
  8. Segatore Milena, Understanding Chronic Pain after Spinal Cord Injury : , 10.1097/01376517-199408000-00007
  9. Cairns DM, Adkins RH, Scott MD (1996) Pain and depression in acute traumatic spinal cord injury: origins of chronic problematic pain? Arch Phys Med Rehab 77:329–335
  10. Felix ER, Cruz-Almeida Y, Widerström-Noga EG (2007) Chronic pain after spinal cord injury: what characteristics make some pains more disturbing than others? J Rehabil Res Dev 44:703–716
  11. Widerström-Noga EG, Felipe-Cuervo E, Yezierski RP (2001) Relationships among clinical characteristics of chronic pain after spinal cord injury. Arch Phys Med Rehabil 82:1191–1197
  12. Turner JA, Cardenas DD, Warms CA, McClellan CB (2001) Chronic pain associated with spinal cord injuries: a community survey. Arch Phys Med Rehabil 82:501–509
  13. Watson BD, Prado R, Dietrich WD, Ginsburg MD, Green BA (1996) Photochemically induced spinal cord injury in the rat. Brain Res 367:296–300
  14. Yezierski RP, Liu S, Ruenes GL, Kajander KJ, Brewer KL (1998) Excitotoxic spinal cord injury: behavioral and morphological characteristics of a central pain model. Pain 75:141–155
  15. Gorman AL, Yu CG, Ruenes GR, Daniels L, Yezierski RP (2001) Conditions affecting the onset, severity, and progression of a spontaneous pain-like behavior after excitotoxic spinal cord injury. J Pain 2:229–240
  16. Yu CG, Fairbanks CA, Wilcox GL, Yezierski RP (2003) Effects of agmatine, interleukin-10, and cyclosporin on spontaneous pain behavior after excitotoxic spinal cord injury in rats. J Pain 4:129–140
  17. Christensen MD, Everhart AW, Pickelman JT, Hulsebosch CE (1996) Mechanical and thermal allodynia in chronic central pain following spinal cord injury. Pain 68:97–107
  18. Hains BC, Chastain KM, Everhart AW, McAdoo DJ, Hulsebosch CE (2000) Transplants of adrenal medullary chromaffin cells reduce forelimb and hindlimb allodynia in a rodent model of chronic central pain after spinal cord hemisection injury. Exp Neurol 164:426–437
  19. Hains BC, Yucra JA, Hulsebosch CE (2001a) Reduction of pathological and behavioral deficits following spinal cord contusion injury with the selective cyclooxygenase-2 inhibitor NS-398. J Neurotrauma 18:409–423
  20. Hains BC, Everhart AW, Fullwood SD, Hulsebosch CE (2002) Changes in serotonin, serotonin transporter expression and serotonin denervation supersensitivity: involvement in chronic central pain after spinal hemisection in the rat. Exp Neurol 175:347–362
  21. Gwak YS, Hains BC, Johnson KM, Hulsebosch CE (2004) Effect of age at time of spinal cord injury on behavioral outcomes in rat. J Neurotrauma 21:983–993
  22. Bunge RP (1994) Clinical implications of recent advances in neurotrauma research. In: Salzman SK, Faden AI (eds) The neurobiology of central nervous system trauma. Oxford University Press, New York, pp 328–339
  23. Metz GA, Curt A, van de Meent H, Klusman I, Schwab ME, Dietz V (2000) Validation of the weight-drop contusion model in rats: a comparative study of human spinal cord injury. J Neurotrauma 17:1–17
  24. Gruner JA (1992) A monitored contusion model of spinal cord injury in the rat. J Neurotrauma 9:123–126
  25. Basso DM, Beattie MS, Bresnahan JC (1996) Graded histological and locomotor outcomes after spinal cord contusion using the NYU weight-drop device versus transection. Exp Neurol 139:244–256
  26. Mills CD, Xu GY, McAdoo DJ, Hulsebosch CE (2001a) Involvement of metabotropic glutamate receptors in excitatory amino acid and GABA release following spinal cord injury in rat. J Neurochem 79:835–848
  27. Hulsebosch CE, Hains BC, Waldrep K, Young W (2000) Bridging the gap: from discovery to clinical trials in spinal cord injury. J Neurotrauma 17:1117–1128
  28. Lindsey Amy E., LoVerso Rebecca L., Tovar C. Amy, Hill Caitlin E., Beattie Michael S., Bresnahan Jacqueline C., An Analysis of Changes in Sensory Thresholds to Mild Tactile and Cold Stimuli after Experimental Spinal Cord Injury in the Rat, 10.1177/154596830001400405
  29. Mills CD, Hains BC, Johnson KM, Hulsebosch CE (2001b) Strain and model differences in behavioral outcomes after spinal cord injury in rat. J Neurotrauma 18:743–745
  30. Tasker RR, Dostrovsky JO (1989) Deafferentation and central pain. In: Wall PD, Melzack R (eds) Textbook of pain. Churchill Livingstone, New York, pp 154–180
  31. Lin Q, Peng YB, Willis WD (2006) Antinociception and inhibition from the periaqueductal gray are mediated in part by spinal 5-hydroxytryptamine1A receptors. J Pharm Exp Ther 276:958–967
  32. Peng YB, Lin Q, Willis WD (1996) The role of 5-HT3 receptors in periaqueductal gray-induced inhibition of nociceptive dorsal horn neurons in rats. J Pharm Exp Ther 276:116–124
  33. Hao JX, Xu XJ, Aldskogious H, Seiger A, Wiesenfield-Hallin Z (1991) Allodynia like effects in rat after ischemic spinal cord injury photochemically induced by laser irradiation. Pain 45:175–185
  34. Yezierski RP, Park SH (1993) The mechanosensitivity of spinal sensory neurons following intraspinal injections of quisqualic acid in the rat. Neurosci Lett 157:115–119
  35. Drew GM, Siddall PJ, Duggan AW (2004) Mechanical allodynia following contusion injury of the rat spinal cord is associated with loss of GABAergic inhibition in the dorsal horn. Pain 3:379–388
  36. Hains BC, Klein JP, Saab CY, Craner MJ, Black JA, Waxman SG (2003a) Upregulation of sodium channel Nav1.3 and functional involvement in neuronal hyperexcitability associated with central neuropathic pain after spinal cord injury. J Neurosci 23:8881–8892
  37. Hains BC, Johnson KM, Eaton MJ, Willis WD, Hulsebosch CE (2003b) Serotonergic neural precursor cell grafts attenuate bilateral hyperexcitability of dorsal horn neurons after spinal hemisection in rat. Neuroscience 116:1097–1110
  38. Hains Bryan C., Willis William D., Hulsebosch Claire E., Serotonin receptors 5-HT1A and 5-HT3 reduce hyperexcitability of dorsal horn neurons after chronic spinal cord hemisection injury in rat, 10.1007/s00221-002-1352-x
  39. Lampert A, Hains BC, Waxman SG (2006) Upregulation of persistent and ramp sodium current in dorsal horn neurons after spinal cord injury. Exp Brain Res 174:660–666
  40. Waxman SG, Hains BC (2006) Fire and phantoms after spinal cord injury: Na+ channels and central pain. Trends Neurosci 29:207–215
  41. Hains BC, Waxman SG (2007) Sodium channel expression and the molecular pathophysiology of pain after SCI. Prog Brain Res 161:195–203
  42. Felts PA, Yokoyama S, Dib-Hajj S, Black JA, Waxman SG (1997) Sodium channel alpha-subunit mRNAs I, II, III, NaG, Na6 and hNE (PN1): different expression patterns in developing rat nervous system. Mol Brain Res 45:71–82
  43. Cummins TR, Aglieco F, Renganathan M, Herzog RI, Dib-Hajj SD, Waxman SG (2001) Nav1.3 sodium channels: rapid repriming and slow closed-state inactivation display quantitative differences after expression in a mammalian cell line and in spinal sensory neurons. J Neurosci 21:5952–5961
  44. Hains BC, Saab CY, Waxman SG (2006) Alterations in burst firing of thalamic VPL neurons and reversal by Nav1.3 antisense after spinal cord injury. J Neurophysiol 95:3343–3352
  45. Hains BC, Saab CY, Waxman SG (2005) Changes in electrophysiological properties and sodium channel Nav1.3 expression in thalamic neurons after spinal cord injury. Brain 128:2359–2371
  46. Hubscher CH, Johnson RD (2006) Chronic spinal cord injury induced changes in the responses of thalamic neurons. Exp Neurol 197:177–188
  47. Zhao P, Waxman SG, Hains BC (2007b) Modulation of thalamic nociceptive processing after SCI through remote activation of thalamic microglia by cysteine–cysteine chemokine ligand 21 (CCL21). J Neurosci 27:8893–8902
  48. Hains BC, Johnson KM, McAdoo DJ, Eaton MJ, Hulsebosch CE (2001b) Engraftment of serotonergic precursors enhances locomotor function and attenuates chronic central pain behavior following spinal hemisection injury in the rat. Exp Neurol 171:361–378
  49. Bowery NG, Hudson AL, Price GW (1987) GABAA and GABAB receptor site distribution in the rat central nervous system. Neuroscience 20:365–383
  50. Zhang AL, Hao JX, Seiger A, Xu XJ, Wiesenfeld-Hallin Z, Grant G, Aldskogius H (1994a) Decreased GABA immunoreactivity in spinal cord dorsal horn neurons after transient spinal cord ischemia in the rat. Brain Res 656:187–190
  51. Zhang RX, Mi ZP, Qiao JT (1994b) Changes of spinal substance P, calcitonin gene-related peptide, somatostatin, Met-enkephalin and neurotensin in rats in response to formalin-induced pain. Regul Pept 51:25–32
  52. Gwak YS, Tan HY, Nam TS, Paik KS, Hulsebosch CE, Leem JW (2006) Activation of spinal GABA receptors attenuates chronic central neuropathic pain after spinal cord injury. J Neurotrauma 23:1111–1124
  53. Mills CD, Johnson KM, Hulsebosch CE (2002) Group I metabotropic glutamate receptors in spinal cord injury: roles in neuroprotection and the development of chronic central pain. J Neurotrauma 19:23–42
  54. Chang HT (2006) Subacute human spinal cord contusion: few lymphocytes and many macrophages. Spinal Cord 45:174–182
  55. Popovich PG, Wei P, Stokes BT (1997) Cellular inflammatory response after spinal cord injury in Sprague–Dawley and Lewis rats. J Comp Neurol 377:443–464
  56. Sroga JM, Jones TB, Kigerl KA, McGaughy VM, Popovich PG (2003) Rats and mice exhibit distinct inflammatory reactions after spinal cord injury. J Comp Neurol 462:223–240
  57. Nesic O, Lee J, Johnson KM, Ye Z, Xu GY, Unabia GC, Wood TG, McAdoo DJ, Westlund KN, Hulsebosch CE, Perez-Polo JR (2005) Transcriptional profiling of spinal cord injury-induced central neuropathic pain. J Neurochem 95:998–1014
  58. Zai LJ, Wrathall JR (2005) Cell proliferation and replacement following contusive spinal cord injury. Glia 50:247–257
  59. Crown ED, Ye Z, Johnson KM, Xu GY, McAdoo DJ, Hulsebosch CE (2006) Increases in the activated forms of ERK 1/2, p38 MAPK, and CREB are correlated with the expression of at-level mechanical allodynia following spinal cord injury. Exp Neurol 199:397–407
  60. Hains BC, Waxman SG (2006) Activated microglia contribute to the maintenance of chronic pain after spinal cord injury. J Neurosci 26:4308–4317
  61. Zhao P, Waxman SG, Hains BC (2007a) ERK-regulated microglia-neuron signaling by prostaglandin E2 underlies pain following spinal cord injury. J Neurosci 27:2357–2368
  62. McMahon SB, Cafferty WB, Marchand F (2005) Immune and glial cell factors as pain mediators and modulators. Exp Neurol 192:444–462
  63. Hua XY, Svensson CI, Matsui T, Fitzsimmons B, Yaksh TL, Webb M (2005) Intrathecal minocycline attenuates peripheral inflammation-induced hyperalgesia by inhibiting p38 MAPK in spinal microglia. Eur J Neurosci 22:2431–2440
  64. Ferrari D, Chiozzi P, Falzoni S, Dal Susino M, Melchiorri L, Baricordi OR, Di Virgilio F (1997) Extracellular ATP triggers IL-1 beta release by activating the purinergic P2Z receptor of human macrophages. J Immunol 159:1451–1458
  65. Coull JA, Beggs S, Boudreau D, Boivin D, Tsuda M, Inoue K, Gravel C, Salter MW, De Koninck Y (2005) BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature 438:1017–1021
  66. Akundi RS, Candelario-Jalil E, Hess S, Hull M, Lieb K, Gebicke-Haerter PJ, Fiebich BL (2005) Signal transduction pathways regulating cyclooxygenase-2 in lipopolysaccharide-activated primary rat microglia. Glia 51:199–208
  67. Ikeda-Matsuo Y, Ikegaya Y, Matsuki N, Uematsu S, Akira S, Sasaki Y (2005) Microglia-specific expression of microsomal prostaglandin E2 synthase-1 contributes to lipopolysaccharide-induced prostaglandin E2 production. J Neurochem 94:1546–1558
  68. Inoue K (2006) ATP receptors of microglia involved in pain. Novartis Found Symp 276:263–272
  69. Minami T, Okuda-Ashitaka E, Hori Y, Sakuma S, Sugimoto T, Sakimura K, Mishina M, Ito S (1999) Involvement of primary afferent C-fibres in touch-evoked pain (allodynia) induced by prostaglandin E2. Eur J Neurosci 11:1849–1856
  70. Ji RR, Kohno T, Moore KA, Woolf CJ (2003) Central sensitization and LTP: do pain and memory share similar mechanisms? Trends Neurosci 26:696–705
  71. Ondarza AB, Ye Z, Hulsebosch CE (2003) Direct evidence of primary afferent sprouting in distant segments following spinal cord injury in the rat: colocalization of GAP-43 and CGRP. Exp Neurol 184:373–380
  72. Willis WD, Coggeshall RE (2004) Sensory mechanisms of the spinal cord, 3rd edn. Plenum, New York
  73. Ribeiro-da-Silva A., Ultrastructural features of the colocalization of calcitonin gene related peptide with substance P or somatostatin in the dorsal horn of the spinal cord, 10.1139/y95-130
  74. Boer PA, Gontijo JA (2006) Nuclear localization of SP, CGRP, and NK1R in a subpopulation of dorsal root ganglia subpopulation cells in rats. Cell Mol Neurobiol 26:191–207
  75. Brooks JW, Thompson SW, Rice AS, Malcangio M (2004) (S)-AMPA inhibits electrically evoked calcitonin gene-related peptide (CGRP) release from the rat dorsal horn: reversal by cannabinoid receptor antagonist SR141716A. Neurosci Lett 372:85–88
  76. Seybold V. S., Galeazza M. T., Garry M. G., Hargreaves K. M., Plasticity of calcitonin gene related peptide neurotransmission in the spinal cord during peripheral inflammation, 10.1139/y95-141
  77. Kangrga I, Randic M (1990) Tachykinins and calcitonin gene-related peptide enhance release of endogenous glutamate and aspartate from the rat spinal dorsal horn slice. J Neurosci 10:2026–2038
  78. Yan Y, Yu LC (2004) Involvement of opioid receptors in the CGRP8-37-induced inhibition of the activity of wide-dynamic-range neurons in the spinal dorsal horn of rats. J Neurosci Res 77:148–152
  79. Bird GC, Han JS, Fu Y, Adwanikar H, Willis WD, Neugebauer V (2006) Pain-related synaptic plasticity in spinal dorsal horn neurons: role of CGRP. Mol Pain 2:31
  80. Oku R, Satoh M, Fujii N, Otaka A, Yajima H, Takagi H (1987) Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from the spinal dorsal horn in rats. Brain Res 403:350–354
  81. Sun RQ, Lawand NB, Willis WD (2003) The role of calcitonin gene-related peptide (CGRP) in the generation and maintenance of mechanical allodynia and hyperalgesia in rats after intradermal injection of capsaicin. Pain 104:201–208
  82. Yezierski RP, Yu CG, Mantyh PW, Vierck CJ, Lappi DA (2004) Spinal neurons involved in the generation of at-level pain following spinal injury in the rat. Neurosci Lett 361:232–236
  83. Nakatsuka T, Chen M, Takeda D, King C, Ling J, Xing H, Ataka T, Vierck C, Yezierski R, Gu JG (2005) Substance P-driven feed-forward inhibitory activity in the mammalian spinal cord. Mol Pain 29(1):20
  84. Jones EG (1998) Viewpoint: the core and matrix of thalamic organization. Neuroscience 85:331–345
  85. Lenz FA, Lee JI, Garonzik IM, Rowland LH, Dougherty PM, Hua SE (2000) Plasticity of pain-related neuronal activity in the human thalamus. Prog Brain Res 129:259–273
  86. Morrow TJ, Paulson PE, Brewer KL, Yezierski RP, Casey KL (2000) Chronic, selective forebrain responses to excitotoxic dorsal horn injury. Exp Neurol 161:220–226
  87. Pattany PM, Yezierski RP, Widerström-Noga EG, Bowen BC, Martinez-Arizala A, Garcia BR, Quencer RM (2002) Proton magnetic resonance spectroscopy of the thalamus in patients with chronic neuropathic pain after spinal cord injury. Am J Neuroradiol 23:901–905
  88. Woolf CJ, Shortland P, Coggeshall RE (1992) Peripheral nerve injury triggers central sprouting of myelinated afferents. Nature 355:75–78
  89. Woolf CJ, Shortland P, Reynolds M, Ridings J, Doubell T, Coggeshall RE (1995) Reorganization of central terminals of myelinated primary afferents in the rat dorsal horn following peripheral axotomy. J Comp Neurol 360:121–134
  90. Nakamura S, Myers RR (1999) Myelinated afferents sprout into lamina II of L3–5 dorsal horn following chronic constriction nerve injury in rats. Brain Res 818:285–290
  91. Kohama I, Ishikawa K, Kocsis JD (2000) Synaptic reorganization in the substantia gelatinosa after peripheral nerve neuroma formation: aberrant innervation of lamina II neurons by Abeta afferents. J Neurosci 20:1538–1549
  92. Weaver LC, Cassam AK, Krassioukov AV, Llewellyn-Smith IJ (1997) Changes in immunoreactivity for growth associated protein-43 suggest reorganization of synapses on spinal sympathetic neurons after cord transection. Neuroscience 81:535–551
  93. Wong ST, Atkinson BA, Weaver LC (2000) Confocal microscopic analysis reveals sprouting of primary afferent fibres in rat dorsal horn after spinal cord injury. Neurosci Lett 296:65–68
  94. Kalous A, Osborne PB, Keast JR (2007) Acute and chronic changes in dorsal horn innervation by primary afferents and descending supraspinal pathways after spinal cord injury. J Comp Neurol 504:238–253
  95. Ackery AD, Norenberg MD, Krassioukov A (2007) Calcitonin gene-related peptide immunoreactivity in chronic human spinal cord injury. Spinal Cord 45:678–686
  96. Bennett AD, Chastain KM, Hulsebosch CE (2000) Alleviation of mechanical and thermal allodynia by CGRP(8–37) in a rodent model of chronic central pain. Pain 86:163–175
  97. Tessier-Lavigne M, Goodman CS (1996) The molecular biology of axon guidance. Science 274:1123–1133
  98. Fawcett JW (1997) Astrocytic and neuronal factors affecting axon regeneration in the damaged central nervous system. Cell Tissue Res 290:371–377
  99. Joosten EA (1997) Corticospinal tract regrowth. Prog Neurobiol 53:1–25
  100. Brook GA, Houweling DA, Gieling RG, Hermanns T, Joosten EA, Bar DP, Gispen WH, Schmitt AB, Leprince P, Noth J, Nacimiento W (2000) Attempted endogenous tissue repair following experimental spinal cord injury in the rat: involvement of cell adhesion molecules L1 and NCAM? Eur J Neurosci 12:3224–3238
  101. Xu XM, Guenard V, Kleitman N, Bunge MB (1995) Axonal regeneration into Schwann cell-seeded guidance channels grafted into transected adult rat spinal cord. J Comp Neurol 351:145–160
  102. Martin D, Robe P, Franzen R, Delree P, Schoenen J, Stevenaert A, Moonen G (1996) Effects of Schwann cell transplantation in a contusion model of rat spinal cord injury. J Neurosci Res 45:588–597
  103. Deumens R, Lubbers M, Jaken RJ, Meijs MF, Thurlings RM, Honig WM, Schachner M, Brook GA, Joosten EA (2007) Mice lacking L1 have reduced CGRP fibre in-growth into spinal transection lesions. Neurosci Lett 420:277–281
  104. Carlstedt T, Cullheim S, Risling M, Ulfhake B (1988) Mammalian root-spinal cord regeneration. Prog Brain Res 78:225–229
  105. Adcock KH, Brown DJ, Shearer MC, Shewan D, Schachner M, Smith GM, Geller HM, Fawcett JW (2004) Axon behaviour at Schwann cell - astrocyte boundaries: manipulation of axon signalling pathways and the neural adhesion molecule L1 can enable axons to cross. Eur J Neurosci 20:1425–1435
  106. Averill S, McMahon SB, Clary DO, Reichardt LF, Priestley JV (1995) Immunocytochemical localization of trkA receptors in chemically identified subgroups of adult rat sensory neurons. Eur J Neurosci 7:1484–1494
  107. Gwak YS, Nam TS, Paik KS, Hulsebosch CE, Leem JW (2003) Attenuation of mechanical hyperalgesia following spinal cord injury by administration of antibodies to nerve growth factor in the rat. Neurosci Lett 336:117–120
  108. Krenz NR, Weaver LC (2000) Nerve growth factor in glia and inflammatory cells of the injured rat spinal cord. J Neurochem 74:730–739
  109. Wang ZH, Walter GF, Gerhard L (1996) The expression of nerve growth factor receptor on Schwann cells and the effect of these cells on the regeneration of axons in traumatically injured human spinal cord. Acta Neuropathol (Berl) 91:180–184
  110. Woolfe F, Waxman SG, Hains BC (2007) In silico modeling of axonal reconnection within a discrete fiber tract after spinal cord injury. J Neurotrauma 24:421–432
  111. Bradbury EJ, McMahon SB (2006) Spinal cord repair strategies: why do they work? Nat Rev Neurosci 7:644–653
  112. Thuret S, Moon LD, Gage FH (2006) Therapeutic interventions after spinal cord injury. Nat Rev Neurosci 7:628–643
  113. Yiu G, He Z (2006) Glial inhibition of CNS axon regeneration. Nat Rev Neurosci 7:617–627
  114. Priestley JV (2007) Promoting anatomical plasticity and recovery of function after traumatic injury to the central or peripheral nervous system. Brain 130:895–897
  115. Deumens R, Koopmans GC, Joosten EA (2005) Regeneration of descending axon tracts after spinal cord injury. Prog Neurobiol 77:57–89
  116. Willerth SM, Sakiyama-Elbert SE (2008) Cell therapy for spinal cord regeneration. Adv Drug Deliv Rev 60:263–276
  117. Caroni P, Schwab ME (1988a) Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron 1:85–96
  118. Caroni P, Schwab ME (1988b) Two membrane protein fractions from rat central myelin with inhibitory properties for neurite growth and fibroblast spreading. J Cell Biol 106:1281–1288
  119. Schwab ME, Caroni P (1988) Oligodendrocytes and CNS myelin are nonpermissive substrates for neurite growth and fibroblast spreading in vitro. J Neurosci 8:2381–2393
  120. GrandPre T, Nakamura F, Vartanian T, Strittmatter SM (2000) Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature 403:439–444
  121. Liu BP, Fournier A, GrandPre T, Strittmatter SM (2002) Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science 297:1190–1193
  122. Wang KC, Koprivica V, Kim JA, Sivasankaran R, Guo Y, Neve RL, He Z (2002) Oligodendrocyte–myelin glycoprotein is a Nogo receptor ligand that inhibits neurite outgrowth. Nature 417:941–944
  123. Fournier AE, GrandPre T, Strittmatter SM (2001) Identification of a receptor mediating Nogo-66 inhibition of axonal regeneration. Nature 409:341–346
  124. Fournier AE, Takizawa BT, Strittmatter SM (2003) Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci 23:1416–1423
  125. Wong ST, Henley JR, Kanning KC, Huang KH, Bothwell M, Poo MM (2002) A p75(NTR) and Nogo receptor complex mediates repulsive signaling by myelin-associated glycoprotein. Nat Neurosci 5:1302–1308
  126. Mi S, Lee X, Shao Z, Thill G, Ji B, Relton J, Levesque M, Allaire N, Perrin S, Sands B et al (2004) LINGO-1 is a component of the Nogo-66 receptor/p75 signaling complex. Nat Neurosci 7:221–228
  127. Shao Z, Browning JL, Lee X, Scott ML, Shulga-Morskaya S, Allaire N, Thill G, Levesque M, Sah D, McCoy JM et al (2005) TAJ/TROY, an orphan TNF receptor family member, binds Nogo-66 receptor 1 and regulates axonal regeneration. Neuron 45:353–359
  128. GrandPre T, Li S, Strittmatter SM (2002) Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature 417:547–551
  129. Zheng B, Atwal J, Ho C, Case L, He XL, Garcia KC, Steward O, Tessier-Lavigne M (2005) Genetic deletion of the Nogo receptor does not reduce neurite inhibition in vitro or promote corticospinal tract regeneration in vivo. Proc Natl Acad Sci USA 102:1205–1210
  130. Cafferty WB, Strittmatter SM (2006) The Nogo–Nogo receptor pathway limits a spectrum of adult CNS axonal growth. J Neurosci 26:12242–12250
  131. Davies SJ, Fitch MT, Memberg SP, Hall AK, Raisman G, Silver J (1997) Regeneration of adult axons in white matter tracts of the central nervous system. Nature 390:680–683
  132. Davies SJ, Goucher DR, Doller C, Silver J (1999) Robust regeneration of adult sensory axons in degenerating white matter of the adult rat spinal cord. J Neurosci 19:5810–5822
  133. Morgenstern DA, Asher RA, Fawcett JW (2002) Chondroitin sulphate proteoglycans in the CNS injury response. Prog Brain Res 137:313–332
  134. Silver J, Miller JH (2004) Regeneration beyond the glial scar. Nat Rev Neurosci 5:146–156
  135. Crespo D, Asher RA, Lin R, Rhodes KE, Fawcett JW (2007) How does chondroitinase promote functional recovery in the damaged CNS? Exp Neurol 206:159–171
  136. Zuo J, Neubauer D, Dyess K, Ferguson TA, Muir D (1998) Degradation of chondroitin sulfate proteoglycan enhances the neurite-promoting potential of spinal cord tissue. Exp Neurol 154:654–662
  137. Fidler PS, Schuette K, Asher RA, Dobbertin A, Thornton SR, Calle-Patino Y, Muir E, Levine JM, Geller HM, Rogers JH et al (1999) Comparing astrocytic cell lines that are inhibitory or permissive for axon growth: the major axon-inhibitory proteoglycan is NG2. J Neurosci 19:8778–8788
  138. Ughrin YM, Chen ZJ, Levine JM (2003) Multiple regions of the NG2 proteoglycan inhibit neurite growth and induce growth cone collapse. J Neurosci 23:175–186
  139. Bradbury EJ, Moon LD, Popat RJ, King VR, Bennett GS, Patel PN, Fawcett JW, McMahon SB (2002) Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416:636–640
  140. Barritt AW, Davies M, Marchand F, Hartley R, Grist J, Yip P, McMahon SB, Bradbury EJ (2006) Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J Neurosci 26:10856–10867
  141. De Winter F, Oudega M, Lankhorst AJ, Hamers FP, Blits B, Ruitenberg MJ, Pasterkamp RJ, Gispen WH, Verhaagen J (2002) Injury-induced class 3 semaphorin expression in the rat spinal cord. Exp Neurol 175:61–75
  142. Kaneko S, Iwanami A, Nakamura M, Kishino A, Kikuchi K, Shibata S, Okano HJ, Ikegami T, Moriya A, Konishi O et al (2006) A selective Sema3A inhibitor enhances regenerative responses and functional recovery of the injured spinal cord. Nat Med 12:1380–1389
  143. Agudo M, Robinson M, Cafferty W, Bradbury EJ, Kilkenny C, Hunt SP, McMahon SB (2005) Regulation of neuropilin 1 by spinal cord injury in adult rats. Mol Cell Neurosci 28:475–484
  144. Tang XQ, Tanelian DL, Smith GM (2004) Semaphorin3A inhibits nerve growth factor-induced sprouting of nociceptive afferents in adult rat spinal cord. J Neurosci 24:819–827
  145. Doucette R (1990) Glial influences on axonal growth in the primary olfactory system. Glia 3:433–449
  146. Franklin RJ, Barnett SC (2000) Olfactory ensheathing cells and CNS regeneration: the sweet smell of success? Neuron 28:15–18
  147. Raisman G (2001) Olfactory ensheathing cells—another miracle cure for spinal cord injury? Nat Rev Neurosci 2:369–375
  148. Li Y, Field PM, Raisman G (1997) Repair of adult rat corticospinal tract by transplants of olfactory ensheathing cells. Science 277:2000–2002
  149. Ramon-Cueto A, Cordero MI, Santos-Benito FF, Avila J (2000) Functional recovery of paraplegic rats and motor axon regeneration in their spinal cords by olfactory ensheathing glia. Neuron 25:425–435
  150. Lu J, Feron F, Mackay-Sim A, Waite PM (2002) Olfactory ensheathing cells promote locomotor recovery after delayed transplantation into transected spinal cord. Brain 125:14–21
  151. Keyvan-Fouladi N, Raisman G, Li Y (2003) Functional repair of the corticospinal tract by delayed transplantation of olfactory ensheathing cells in adult rats. J Neurosci 23:9428–9434
  152. Ruitenberg MJ, Levison DB, Lee SV, Verhaagen J, Harvey AR, Plant GW (2005) NT-3 expression from engineered olfactory ensheathing glia promotes spinal sparing and regeneration. Brain 128:839–853
  153. Deumens R., Koopmans G.C., Honig W.M.M., Hamers F.P.T., Maquet V., Jérôme R., Steinbusch H.W.M., Joosten E.A.J., Olfactory ensheathing cells, olfactory nerve fibroblasts and biomatrices to promote long-distance axon regrowth and functional recovery in the dorsally hemisected adult rat spinal cord, 10.1016/j.expneurol.2006.01.030
  154. Deumens R, Koopmans GC, Honig WM, Maquet V, Jerome R, Steinbusch HW, Joosten EA (2006b) Chronically injured corticospinal axons do not cross large spinal lesion gaps after a multifactorial transplantation strategy using olfactory ensheathing cell/olfactory nerve fibroblast–biomatrix bridges. J Neurosci Res 83:811–820
  155. Steward O, Sharp K, Selvan G, Hadden A, Hofstadter M, Au E, Roskams J (2006) A re-assessment of the consequences of delayed transplantation of olfactory lamina propria following complete spinal cord transection in rats. Exp Neurol 198:483–499
  156. Franssen EH, de Bree FM, Verhaagen J (2007) Olfactory ensheathing glia: their contribution to primary olfactory nervous system regeneration and their regenerative potential following transplantation into the injured spinal cord. Brain Res Rev 56:236–258
  157. Richter MW, Fletcher PA, Liu J, Tetzlaff W, Roskams AJ (2005) Lamina propria and olfactory bulb ensheathing cells exhibit differential integration and migration and promote differential axon sprouting in the lesioned spinal cord. J Neurosci 25:10700–10711
  158. Richter MW, Roskams AJ (2008) Olfactory ensheathing cell transplantation following spinal cord injury: hype or hope? Exp Neurol 209:353–367
  159. Kauppila T (1998) Correlation between autotomy-behavior and current theories of neuropathic pain. Neurosci Biobehav Rev 23:111–129
  160. Boyd JG, Lee J, Skihar V, Doucette R, Kawaja MD (2004) LacZ-expressing olfactory ensheathing cells do not associate with myelinated axons after implantation into the compressed spinal cord. Proc Natl Acad Sci USA 101:2162–2166
  161. Ramer LM, Au E, Richter MW, Liu J, Tetzlaff W, Roskams AJ (2004) Peripheral olfactory ensheathing cells reduce scar and cavity formation and promote regeneration after spinal cord injury. J Comp Neurol 473:1–15
  162. Cao L, Zhu YL, Su Z, Lv B, Huang Z, Mu L, He C (2007) Olfactory ensheathing cells promote migration of Schwann cells by secreted nerve growth factor. Glia 55:897–904
  163. Cao Q, Xu XM, Devries WH, Enzmann GU, Ping P, Tsoulfas P, Wood PM, Bunge MB, Whittemore SR (2005) Functional recovery in traumatic spinal cord injury after transplantation of multineurotrophin-expressing glial-restricted precursor cells. J Neurosci 25:6947–6957
  164. Cummings BJ, Uchida N, Tamaki SJ, Salazar DL, Hooshmand M, Summers R, Gage FH, Anderson AJ (2005) Human neural stem cells differentiate and promote locomotor recovery in spinal cord-injured mice. Proc Natl Acad Sci USA 102:14069–14074
  165. Keirstead HS, Nistor G, Bernal G, Totoiu M, Cloutier F, Sharp K, Steward O (2005) Human embryonic stem cell-derived oligodendrocyte progenitor cell transplants remyelinate and restore locomotion after spinal cord injury. J Neurosci 25:4694–4705
  166. Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR (2000) Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science 290:1779–1782
  167. Lu P, Jones LL, Snyder EY, Tuszynski MH (2003) Neural stem cells constitutively secrete neurotrophic factors and promote extensive host axonal growth after spinal cord injury. Exp Neurol 181:115–129
  168. Hofstetter CP, Holmstrom NA, Lilja JA, Schweinhardt P, Hao J, Spenger C, Wiesenfeld-Hallin Z, Kurpad SN, Frisen J, Olson L (2005) Allodynia limits the usefulness of intraspinal neural stem cell grafts; directed differentiation improves outcome. Nat Neurosci 8:346–353
  169. Davies JE, Proschel C, Noble M, Mayer-Proschel M, Davies SJ (2007) Transplanted type-2 astrocytes derived from embryonic glial precursors fail to support functional recovery after spinal cord injury and promote neuropathic pain. Abstract Viewer/Itinerary Planner San Diego: Society for Neuroscience Program no. 137.18
  170. Joosten EA, Veldhuis WB, Hamers FP (2004) Collagen containing neonatal astrocytes stimulates regrowth of injured fibers and promotes modest locomotor recovery after spinal cord injury. J Neurosci Res 77:127–142